Physician profile
Mark S Uhlman
NPI 1942297460
$1,055.03
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $810 · 2020: $130 · 2021: $34.53 · 2022: $12.19 · 2024: $68.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $68.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $68.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $427.25 | 2019-2021 | |
| Janssen Biotech, INC. | $102.66 | 2019-2024 | Erleada |
| Abbvie INC. | $101.87 | 2019 | |
| Pfizer INC. | $78.24 | 2019-2020 | |
| Medtronic USA, INC. | $69.90 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $52.17 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $48.62 | 2019 | |
| Dendreon Pharmaceuticals LLC | $40.31 | 2019 | |
| Ferring Pharmaceuticals INC. | $28.44 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $25.21 | 2019 | |
| Allergan, INC. | $22.89 | 2019 | |
| Rochester Medical Corporation | $13.12 | 2020 | |
| Myriad Genetic Laboratories, INC. | $12.19 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.66 | 2019 | |
| Cook Medical LLC | $11.42 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $9.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Uhlman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.